ClinicalThought

Share

Program Content

Activities

  • 3L+ RR FL FAQs
    Novel Targeted Therapies in Relapsed/Refractory Follicular Lymphoma: Experts Answer Frequently Asked Questions
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 29, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from Genentech, a member of the Roche Group; Genmab; Ipsen Biopharmaceuticals, Inc; and Regeneron Pharmaceuticals, Inc.

Genentech, a member of the Roche Group

Genmab

Ipsen Biopharmaceuticals Inc

Regeneron Pharmaceuticals, Inc